Tema Etfs LLC Takes Position in Procter & Gamble Company (The) $PG

Tema Etfs LLC acquired a new position in Procter & Gamble Company (The) (NYSE:PG) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 41,718 shares of the company’s stock, valued at approximately $6,410,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Halbert Hargrove Global Advisors LLC acquired a new stake in Procter & Gamble in the third quarter worth approximately $25,000. Signature Resources Capital Management LLC raised its stake in shares of Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after buying an additional 72 shares in the last quarter. Corundum Trust Company INC bought a new position in Procter & Gamble during the third quarter valued at about $32,000. Mid American Wealth Advisory Group Inc. acquired a new position in Procter & Gamble during the second quarter worth about $34,000. Finally, RMG Wealth Management LLC bought a new stake in Procter & Gamble in the second quarter worth about $37,000. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $141.81 on Monday. The firm has a 50 day simple moving average of $144.93 and a 200 day simple moving average of $151.45. The firm has a market cap of $331.37 billion, a P/E ratio of 20.70, a P/E/G ratio of 4.79 and a beta of 0.39. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $179.99. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.71 and a quick ratio of 0.51.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, October 24th. The company reported $1.99 EPS for the quarter, beating the consensus estimate of $1.90 by $0.09. The company had revenue of $22.39 billion during the quarter, compared to analysts’ expectations of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.93 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Stockholders of record on Friday, October 24th were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend was Friday, October 24th. Procter & Gamble’s dividend payout ratio is presently 61.75%.

Insider Activity at Procter & Gamble

In related news, CAO Matthew W. Janzaruk sold 725 shares of Procter & Gamble stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $149.57, for a total transaction of $108,438.25. Following the completion of the transaction, the chief accounting officer owned 979 shares in the company, valued at approximately $146,429.03. This trade represents a 42.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.20% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on PG shares. Barclays dropped their price target on Procter & Gamble from $153.00 to $151.00 and set an “equal weight” rating on the stock in a report on Monday, December 8th. UBS Group cut their target price on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Bank of America dropped their price target on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Morgan Stanley set a $175.00 price objective on shares of Procter & Gamble in a research note on Monday, October 27th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, December 29th. Fifteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $169.23.

Procter & Gamble News Roundup

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Seeking Alpha argues the market is wrong and P&G is a buy — the piece upgrades the rating, highlighting durable cash flows and long-term compounding potential that could attract value investors. Procter & Gamble: The Market Is Wrong – It’s Time To Buy This Compounder (Rating Upgrade)
• Positive Sentiment: TD Cowen cut its price target (to $150) but maintained a Buy — signals some near-term valuation cooling yet continued analyst conviction that P&G has upside from current levels. Benzinga
• Neutral Sentiment: Zacks notes P&G is a trending stock and summarizes factors investors should watch (demand trends, promotions, dividend profile), useful for short-term traders but not a firm directional catalyst. Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Analysis on Yahoo Finance frames the story as a trade-off: legal scrutiny vs. new CEO emphasis on pricing — legal risk raises uncertainty, but stronger pricing execution would support margins and investor confidence. Should Legal Scrutiny And New CEO Focus On Pricing Shape Procter & Gamble’s (PG) Investment Narrative?
• Negative Sentiment: Regulatory action: P&G agreed to change Crest kids’ toothpaste packaging after concerns raised by the Texas AG — this creates near-term legal/regulatory overhang and potential reputational risk. Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
• Negative Sentiment: Wells Fargo trimmed its price target (to $158 from $170) as 2026 models were reset — the cut, even with an Overweight call, signals lower near-term upside from previous analyst expectations. Wells Fargo Trims Procter & Gamble (PG) Target as 2026 Models Reset
• Negative Sentiment: Market-watch pieces and a Seeking Alpha “still not a buy” write-up highlight valuation concerns (multiples vs. growth) and recent softness in category demand — these narratives feed selling pressure and explain continued volatility. Procter & Gamble: A Wide Moat, Solid Business – And Still Not A Buy
• Negative Sentiment: Short-term technical/market signal: coverage flagged P&G hitting a 52-week low recently, which can amplify downside momentum as momentum traders and funds react. Procter & Gamble Hits 52-Week Low: Buy Opportunity or Warning Sign?

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.